Tesamorelin

Product Information

Tesamorelin (C221H366N72O67S, 5135.9 g/mol) is a modified GHRH analog that stimulates natural growth hormone production while demonstrating selective effects on visceral adipose tissue. This research peptide mimics GHRH, binds to pituitary receptors, triggers pulsatile GH release, and promotes IGF-1 production. Laboratory research demonstrates 15-20% reduction in abdominal visceral fat over 6-month periods in preclinical models, with enhanced insulin sensitivity and improved glucose metabolism. Research applications focus on visceral fat reduction mechanisms, metabolic health pathways, cognitive function investigations, and growth hormone dynamics. The compound's selective targeting of internal organ fat makes it particularly valuable for understanding adipose tissue heterogeneity. Studies show potential cognitive improvements alongside metabolic effects. Tesamorelin represents a sophisticated tool for investigating the relationship between visceral adiposity and metabolic dysfunction. For laboratory research purposes only.